Some automatic methods have been proposed to identify keratoconus from corneal maps; among these methods, neural networks have proved to be useful. However, the identification of the early cases of this ocular disease remains a problem from both a diagnostic and a screening point of view. Another problem is whether a keratoconus screening must be performed taking into account both eyes of the same subject or each eye separately; hitherto, neural networks have only been used in the second alternative. In order to examine the differences of the two screening alternatives in terms of discriminative capability, several combinations of the number of input, hidden and output nodes and of learning rates have been examined in this study. The best results have been achieved by using as input the parameters of both eyes of the same subject and as output the three categories of clinical classification (normal, keratoconus, other alterations) for each subject, a low number of neurons in the hidden layer (lower than 10) and a learning rate of 0.1. In this case a global sensitivity of 94.1% (with a keratoconus sensitivity of 100%) in the test set as well as a global specificity of 97.6% (98.6% for keratoconus alone) have been reached.
An experimental arrangement capable of monitoring temperature changes from 0.01 to 0.1 K has been successfully tested for registering the temperature evolution occurring during the tetragonal to monoclinic transformation of an alumina/ceria-stabilized tetragonal zirconia polycrystal (AI,O,/Ce-TZP). The arrangement is based on a very small thermistor. The data obtained have been used for evaluating the thermal diffusivity of the Al,OJCe-TZP composites.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.